We recently published an article titled 9 High Growth Canadian Stocks to Buy. In this article, we are going to take a look at ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

Shares of Cronos Group (NASDAQ: CRON) have already more than doubled this year, according to data provided by S&P Global Market Intelligence. The Canadian cannabis producer is benefitting from a host ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company (“GrowCo”).

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 first quarter business results. "2025 is shaping up to be a ...

Shares of Cronos Group Inc. CRON shed 2.63% to $2.59 Thursday, on what proved to be an all-around mixed trading session for ...

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (CRON) (“Cronos” or the “Company”) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET.

Shares of Cronos Group Inc. CRON shed 3.09% to $2.51 Friday, on what proved to be an all-around grim trading session for the ...